Changes in opioid and other analgesic use 1995-2010: Repeated cross-sectional analysis of dispensed prescribing for a large geographical population in Scotland

European Journal of Pain (United Kingdom)

Volumn 19, Issue 1, 2015, Pages 59-66

  Ruscitto, Andrea ^a   Smith, B H ^b   Guthrie, B ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CAPSAICIN; CODEINE; CYCLOOXYGENASE 2 INHIBITOR; DEXTROPROPOXYPHENE; DIHYDROCODEINE; FENTANYL; GABAPENTIN; MEPTAZINOL; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYCODONE; PARACETAMOL; PREGABALIN; TRAMADOL; NARCOTIC ANALGESIC AGENT;

ADULT; ARTICLE; COMMUNITY; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DRUG USE; FEMALE; GEOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUROPATHIC PAIN; POLYPHARMACY; PRESCRIPTION; PRIORITY JOURNAL; REPEAT PROCEDURE; UNITED KINGDOM; AGED; CLINICAL PRACTICE; PAIN; STATISTICS AND NUMERICAL DATA; TRENDS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS; ANALGESICS, OPIOID; CROSS-SECTIONAL STUDIES; DRUG PRESCRIPTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; PRACTICE PATTERNS, PHYSICIANS'; SCOTLAND; YOUNG ADULT;

EID: 84923276977     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1002/ejp.520     Document Type: Article

References (41)

1. Advisory Council on the Misuse of Drugs (2013). ACMD Consideration of Tramadol (London: Advisory Council on the Misuse of Drugs).
2. Ashworth, J., Green, D.J., Dunn, K.M., Jordan, K.P., (2013). Opioid use among low back pain patients in primary care: Is opioid prescription associated with disability at 6-month follow-up? Pain 154, 1038-1044.
3. Barnett, K., Mercer, S.W., Norbury, M., Watt, G., Wyke, S., Guthrie, B., (2012). Epidemiology of multimorbidity and implications for health care, research, and medical education: A cross-sectional study. The Lancet 380, 37-43.
4. Bedson, J., Belcher, J., Martino, O.I., Ndlovu, M., Rathod, T., Walters, K., Dunn, K.M., Jordan, K.P., (2012). The effectiveness of national guidance in changing analgesic prescribing in primary care from 2002 to 2009: An observational database study. Eur J Pain 17, 434-443.
5. Bridges, S., (2012). Chronic pain. In Health Survey for England 2011, R. Craig, J. Mindell, eds. (Leeds: Health and Social Care Information Centre) pp. 291-323.
6. British National Formulary (BNF) (2010). British Medical Association and the Royal Pharmaceutical Society of Great Britain (London: BMJ Group and Pharmaceutical Press).
7. British National Formulary (BNF) (2012). British Medical Association and the Royal Pharmaceutical Society of Great Britain (London: BMJ Group and Pharmaceutical Press).
8. British Pain Society (2010). Opioids for Persistent Pain: Good Practice (London: The British Pain Society).
9. Campbell, C.I., Weisner, C., LeResche, L., Ray, G.T., Saunders, K., Sullivan, M.D., Banta-Green, C.J., Merrill, J.O., Silverberg, M.J., Boudreau, D., (2010). Age and gender trends in long-term opioid analgesic use for noncancer pain. Am J Public Health 100, 2541-2547.
10. Caudill-Slosberg, M.A., Schwartz, L.M., Woloshin, S., (2004). Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 versus 2000. Pain 109, 514-519.
11. Chou, R., Ballantyne, J.C., Fanciullo, G.J., Fine, P.G., Miaskowski, C., (2009). Research gaps on use of opioids for chronic noncancer pain: Findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 10, 147-159, e115.
12. Compton, W.M., Volkow, N.D., (2006). Abuse of prescription drugs and the risk of addiction. Drug Alcohol Depend 83 (Suppl. 1), S4-S7.
13. Dhalla, I.A., Persaud, N., Juurlink, D.N., (2011). Facing up to the prescription opioid crisis. BMJ 343, d5142-d5142.
14. Ettinger, A.B., Argoff, C.E., (2007). Use of antiepileptic drugs for nonepileptic conditions: Psychiatric disorders and chronic pain. Neurother 4, 75-83.
15. Fischer, B., Jones, W., Krahn, M., Rehm, J., (2011). Differences and over-time changes in levels of prescription opioid analgesic dispensing from retail pharmacies in Canada, 2005-2010. Pharmacoepidemiol Drug Saf 20, 1269-1277.
16. Fredheim, O.M.S., Skurtveit, S., Breivik, H., Borchgrevink, P.C., (2010). Increasing use of opioids from 2004 to 2007-Pharmacoepidemiological data from a complete national prescription database in Norway. Eur J Pain 14, 289-294.
17. Hamunen, K., Paakkari, P., Kalso, E., (2009). Trends in opioid consumption in the Nordic countries 2002-2006. Eur J Pain 13, 954-962.
18. Hawton, K., Bergen, H., Simkin, S., Brock, A., Griffiths, C., Romeri, E., Smith, K.L., Kapur, N., Gunnell, D., (2009). Effect of withdrawal of co-proxamol on prescribing and deaths from drug poisoning in England and Wales: Time series analysis. BMJ 338, b2270.
19. Howard, R.L., Avery, A.J., Slavenburg, S., Royal, S., Pipe, G., Lucassen, P., Pirmohamed, M., (2007). Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol 63, 136-147.
20. Information Services Division (2013). Community Dispensing: Prescription Cost Analysis 2013 (Edinburgh: NHS National Services Scotland). [accessed 18/12/13] Available at http://www.isdscotland.org/Health-Topics/Prescribing-and-Medicines/Community-Dispensing/Prescription-Cost-Analysis/ (accessed 18 December 2013).
21. Johannes, C.B., Le, T.K., Zhou, X., Johnston, J.A., Dworkin, R.H., (2010). The Prevalence of chronic pain in United States adults: Results of an internet-based survey. J Pain 11, 1230-1239.
22. Lawson, E., (2011). Lesser-known prescribed and over-the-counter drugs of misuse. Prescriber 22, 12-17.
23. Leong, M., Murnion, B., Haber, P.S., (2009). Examination of opioid prescribing in Australia from 1992 to 2007. Intern Med J 39, 676-681.
24. Medicines and Healthcare Products Regulatory Agency & Commission on Human Medicines (2009). Non-steroidal anti-inflammatory drugs: Cardiovascular risk. Drug Saf Update 2, 3.
25. NICE (2010). Neuropathic Pain: The Pharmacological Management of Neuropathic Pain in Adults in Non-Specialist Settings-CG96 (London: National Institute for Health and Care Excellence).
26. Olsen, Y., Daumit, G.L., Ford, D.E., (2006). Opioid prescriptions by U.S. primary Care physicians from 1992 to 2001. J Pain 7, 225-235.
27. Oteri, A., Trifirò, G., Gagliostro, M.S., Tari, D.U., Moretti, S., Bramanti, P., Spina, E., Caputi, A.P., Arcoraci, V., (2010). Prescribing pattern of anti-epileptic drugs in an Italian setting of elderly outpatients: A population-based study during 2004-07. Br J Clin Pharmacol 70, 514-522.
28. Ponizovsky, A., Marom, E., Zeldin, A., Cherny, N., (2011). Trends in opioid analgesics consumption, Israel, 2000-2008. Eur J Clin Pharmacol 67, 165-168.
29. Reid, K.J., Harker, J., Bala, M.M., Truyers, C., Kellen, E., Bekkering, G.E., Kleijnen, J., (2011). Epidemiology of chronic non-cancer pain in Europe: Narrative review of prevalence, pain treatments and pain impact. Curr Med Res Opin 27, 449-462.
30. Smith, B.H., Elliott, A.M., Chambers, W.A., Smith, W.C., Hannaford, P.C., Penny, K., (2001). The impact of chronic pain in the community. Fam Pract 18, 292-299.
31. Smith, B.H., Torrance, N., (2011). Management of chronic pain in primary care. Curr Opin Support Palliat Care 5, 137-142.
32. Spence, D., (2010). Pain revisited: Evidence for opioids. BMJ 340, c2659.
33. Spina, E., Perugi, G., (2004). Antiepileptic drugs: Indications other than epilepsy. Epileptic Disord 6, 57-76.
34. Stannard, C.F., (2011). Opioids for chronic pain: Promise and pitfalls. Curr Opin Suppor Palliat Care 5, 150-157.
35. The Scottish Government (2008). Scottish Government Urban Rural Classification (Edinburgh: Office of the Chief Statistician).
36. The Scottish Government (2009). Scottish Index of Multiple Deprivation 2009 General Report (Edinburgh: Office of the Chief Statistician).
37. Thielke, S.M., Simoni-Wastila, L., Edlund, M.J., DeVries, A., Martin, B.C., Braden, J.B., Fan, M.-Y., Sullivan, M.D., (2010). Age and sex trends in long-term opioid use in two large american health systems between 2000 and 2005. Pain Med 11, 248-256.
38. Tsiropoulos, I., Gichangi, A., Andersen, M., Bjerrum, L., Gaist, D., Hallas, J., (2006). Trends in utilization of antiepileptic drugs in Denmark. Acta Neurol Scand 113, 405-411.
39. UK Medicines Information (UKMi) Pharmacists for NHS Healthcare Professionals (2011). What are the Equivalent Doses of Oral Morphine to Other Oral Opioids when Used as Analgesics in Adult Palliative Care? (Southampton: Wessex Drug and Information Centre).
40. University of Dundee (2013) Health Informatics Centre. Available from: http://medicine.dundee.ac.uk/hic (accessed on 30 April 2014).
41. Zhang, W., Jones, A., Doherty, M., (2004). Does paracetamol (acetaminophen) reduce the pain of osteoarthritis?: A meta-analysis of randomised controlled trials. Ann Rheum Dis 63, 901-907.